Skip to content

Clinical trials

Terminated Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Terminated Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20025
20033
20047
20051
20066
200710
20085
20094
20109
20112
20123
20133
20143
20164
20173
20182
20193
20204
20212
20226
20236

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated110

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group14
National Cancer Institute (NCI)7
Masonic Cancer Center, University of Minnesota5
Vanderbilt-Ingram Cancer Center5
Amgen3
M.D. Anderson Cancer Center3
Pfizer3
Cancer Research UK2
Lyell Immunopharma, Inc.2
OHSU Knight Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial110
Ovarian Neoplasms69
Fallopian Tube Neoplasms38
Breast Neoplasms20
Carcinoma, Non-Small-Cell Lung12
Burkitt Lymphoma10
Leukemia, Lymphocytic, Chronic, B-Cell10
Leukemia, Myeloid, Acute10
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Follicular10

Trials

Showing 26 to 50 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.